Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • NPPA to undergo...

    NPPA to undergo Restructuring

    Written by Ruby Khatun Khatun Published On 2018-06-07T17:37:48+05:30  |  Updated On 7 Jun 2018 5:37 PM IST
    NPPA to undergo Restructuring
    NPPA to see a shift in its role from Price Fixer to mere Regulator

    New Delhi: Soon the country will be going to have a new form of National Pharmaceutical Pricing Authority (NPPA) as the government is ready to reorganize the regulator.


    According to a recent report in TOI, the government is set to restructure the authority in order to revamp the drug price regulation in the country, while strengthening implementation and market monitoring.


    The authority will be soon going to be renamed and will be replaced by a board or a council with four full-time members, including the chairman. The other three members will be an economist, a costing specialist and a technology expert — will also hold a rank similar to the chairman, according to a proposal being considered at the highest level of the government.


    A government official told TOI, "The proposal was floated by Niti Aayog and discussed in a meeting with the PMO. Largely, there is a consensus on this within the government and therefore, we are expecting a notification by end of this month."


    Currently, the regulator is responsible for regulating drug prices and ensuring the availability of medicines, but the role is expected to change to become more of a regulatory body implementing and monitoring prices in the market, than fixing them.


    At present, NPPA has the powers to cap prices of medicines according to the Drugs Price Control Order. Beside this, it also gives new price approvals and looks at price revisions. The authority also has the powers to regulate prices of all medicines and medical devices under extraordinary circumstances in the public interest.


    The Department of Pharmaceuticals, last year issued orders to restrict the power of the authority to only the medicines and devices notified on the National List of Essential Medicines (NLEM) after the regulator extended the width of price control by bringing in some key drugs as well as stents and knee implants under the purview of price control.

    Cap pricesDrugs Price Control OrdergovernmentInsurance Regulatory and Development Authority of Indiaknee implantsMedical DevicesmedicinesNational List of Essential MedicinesNational Pharmaceutical Pricing AuthorityNiti AayogNLEMNPPAPMOPrice ControlrestructureStentsTelecom Regulatory Authority of India
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok